Cargando…
Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel
Anticancer drugs, such as paclitaxel (PTX), are indispensable for the treatment of a variety of malignancies. However, the application of most drugs is greatly limited by the low water solubility, poor permeability, or high efflux from cells. Nanoparticles have been widely investigated to enable dru...
Autores principales: | Liu, Yongjin, Zhang, Bin, Yan, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155358/ https://www.ncbi.nlm.nih.gov/pubmed/21845085 http://dx.doi.org/10.3390/ijms12074395 |
Ejemplares similares
-
Macrophages as Promising Carriers for Nanoparticle Delivery in Anticancer Therapy
por: Wróblewska, Anna, et al.
Publicado: (2023) -
Clinically Relevant Anticancer Polymer Paclitaxel Therapeutics
por: Yang, Danbo, et al.
Publicado: (2010) -
Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles
por: Esfandyari-Manesh, Mehdi, et al.
Publicado: (2015) -
RETRACTED ARTICLE: Gold Nanoparticles-enabled Efficient Dual Delivery of Anticancer Therapeutics to HeLa Cells
por: Farooq, Muhammad U., et al.
Publicado: (2018) -
Retraction Note: Gold Nanoparticles-enabled Efficient Dual Delivery of Anticancer Therapeutics to HeLa cells
por: Farooq, Muhammad U., et al.
Publicado: (2022)